Background-An elevated resting heart rate is associated with rehospitalization for heart failure and is a modifiable risk factor in heart failure patients. We aimed to examine the association between resting heart rate and incident heart failure in a population-based cohort study of healthy adults without pre-existing overt heart disease. Methods and Results-We studied 4768 men and women aged ≥55 years from the population-based Rotterdam Study. We excluded participants with prevalent heart failure, coronary heart disease, pacemaker, atrial fibrillation, atrioventricular block, and those using β-blockers or calcium channel blockers. We used extended Cox models allowing for time-dependent variation of resting heart rate along follow-up. During a median of 14.6 years of follow-up, 656 participants developed heart failure. The risk of heart failure was higher in men with higher resting heart rate. For each increment of 10 beats per minute, the multivariable adjusted hazard ratios in men were 1.16 (95% confidence interval, 1.05-1.28; P=0.005) in the time-fixed heart rate model and 1.13 (95% confidence interval, 1.02-1.25; P=0.017) in the time-dependent heart rate model. The association could not be demonstrated in women (P for interaction=0.004). Censoring participants for incident coronary heart disease or using time-dependent models to account for the use of β-blockers or calcium channel blockers during follow-up did not alter the results. Conclusions-Baseline or persistent higher resting heart rate is an independent risk factor for the development of heart failure in healthy older men in the general population. (Circ Heart Fail. 2013;6:403-410.)
H eart failure is a major public health problem that is associated with substantial mortality and morbidity. 1 In the aging population of Western countries, the incidence of heart failure hospitalization is increasing, despite the improvements in health care for heart failure patients. 2 Therefore, it is important to develop strategies to detect adults at risk of heart failure to better tailor preventive measures and treatment.
Clinical Perspective on p 410
Resting heart rate is a very accessible biological parameter with potential predictive capacity for heart failure and cardiovascular disease. 3 Among patients experiencing heart failure, resting heart rate is a modifiable risk factor to prevent rehospitalization for heart failure. 4 However, studies examining the association between resting heart rate and heart failure have not included adults from the general population, 5 or have included adults with cardiovascular disease, 6 or conduction disorders such as atrial fibrillation, 7 or adults using antiarrhythmics or β-blockers. 8 This research question is important to study in a prospective manner because in cardiac patients, a subclinical decompensated state might enhance a hemodynamic response that increases heart rate. This biological interaction between resting heart rate and subclinical heart failure may limit the interpretation of the role of heart rate in the pathogenesis of heart failure because of potential reverse causality. Thus, it is still uncertain whether the association between resting heart rate and heart failure can be extrapolated to healthy adults from the general population.
We examined whether higher resting heart rate is independently associated with the development of heart failure among adults without pre-existing heart disease or heart ratemodifying medication use in the general population.
Methods

Study Sample
This study was performed within the framework of the Rotterdam Study, a prospective population-based cohort study designed to evaluate the determinants and consequences of chronic diseases in the elderly. Details regarding the objectives and methods of the Rotterdam Study have been reported previously. 9 Briefly, all inhabitants aged ≥55 years of a well-defined suburb in the city of Rotterdam, The Netherlands, were invited to participate and 7983 (78%) were enrolled. The Medical Ethics Committee of the Erasmus Medical Center approved the study and participants gave written informed consent to participate in the study and to obtain information from their treating physicians, separately. From 1990 until 1993, baseline data were collected using standardized home-interviews, and established cardiovascular risk factors were subsequently assessed at the research center.
Of the 7129 individuals in the Rotterdam Study who visited the research center at baseline, heart rate measurement was available for 6966 participants. To account for endogenous heart rate variation only, we further excluded 873 participants using β-blockers and 173 using calcium channel blockers. Because we aimed to examine the association between heart rate and the development of heart failure in participants free of heart disease, we also excluded participants with a pacemaker, second or third degree atrioventricular block on the baseline ECG, a history of heart failure, atrial fibrillation, and those with known coronary heart disease (CHD) defined as a history of myocardial infarction, coronary artery bypass grafting, or percutaneous coronary intervention. 10 The final sample for analysis comprised 4768 participants.
Measurement of Heart Rate
In all participants, baseline resting pulse was measured for 30 s at the right radial artery between 2 consecutive blood pressure measurements at the research center, with the subject in a sitting position. To obtain heart rate in beats per minute, the obtained pulse count was multiplied by 2. Repeated examinations of heart rate were performed every 3 to 4 years and were available for 3 additional follow-up visits, from 1993 to 1995, from 1997 to 1999, and from 2002 to 2004. For sensitivity analysis, resting heart rate was further measured from a 10-s 12-lead ECG at baseline in 4127 participants. Repeated measurements of ECG were available for all 3 additional follow-up visits. All ECGs were recorded with an ACTA Gnosis IV ECG recorder (Esaote Biomedica, Florence, Italy) at a sampling frequency of 500 Hz and stored digitally. All ECGs were processed using the validated modular ECG analysis system. 11 Modular ECG analysis system locates the QRS complexes and determines a stable reference point in each complex. The QRS detector of modular ECG analysis system operates on multiple simultaneously recorded leads, which are transformed to a detection function that brings out the QRS complexes among the other parts of the signal. RR intervals are taken as the intervals between the reference points in adjacent QRS complexes. The median RR interval was computed after exclusion of RR intervals that immediately precede and follow any premature ventricular complex.
Heart Failure Assessment
Prevalent and incident heart failure was determined as defined previously. 1, 10, 12 For prevalent cases, a validated score was used on the basis of heart failure definition of the European Society of Cardiology. 13 This score was based on the presence of ≥2 signs or symptoms suggestive of heart failure or use of medication for the indication of heart failure. 10 Cases of incident heart failure were obtained by continuously monitoring participants during follow-up through automated linkage with files from general practitioners. All available data on heart failure, such as hospital discharge letters and notes from general practitioners, were copied from the medical records. Heart failure was adjudicated in accordance with the criteria of the European Society of Cardiology 13 on the basis of combination of signs and symptoms, and objective evidence of cardiac dysfunction, including chest radiographs or echocardiography. Two independent research physicians adjudicated all potential heart failure cases. In case of disagreement the judgment of a cardiologist was sought and considered decisive. 10 Only definite and probable cases of heart failure were included in the analyses. The date of incident heart failure was the first occurrence of symptoms suggestive of heart failure, or the day of receipt of a first prescription of a loop diuretic or an angiotensin-converting enzyme inhibitor for heart failure. For the present analysis, incident heart failure was adjudicated until January 1, 2009.
Covariables
Hypertension was defined as a systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg or use of blood pressurelowering drugs with the indication of hypertension. Diabetes mellitus was defined as a random or postload blood glucose measurement exceeding 11.0 mmol/L, or the use of antidiabetic drugs. Body mass index was calculated by dividing measured weight by height squared. Assessment of incident fatal and nonfatal CHD has been previously described. 10 For the present analysis, incident CHD events, including myocardial infarction and myocardial revascularization procedures, have been adjudicated until January 1, 2009. For all medication use from January 1, 1991, onward, 8 fully automated pharmacies in the research area provided data on use, dosage, duration of use, and date of first prescription, using a single computer network to register all prescriptions, as previously described. 9, 10 Moreover, data on medication use were collected during the baseline home interview.
Statistical Analysis
Resting heart rate values at baseline were grouped into tertiles. This was done separately for men and women because women are known to have a higher resting heart rate than men.
14 One-way ANOVA and χ 2 tests or the Kruskal-Wallis rank test were used for baseline comparisons between tertiles. We calculated incidence rates per 1000 personyears of follow-up in participants categorized according to their resting heart rate and constructed Kaplan-Meier cumulative incidence curves. The associations between baseline resting heart rate and heart failure were examined in a time-fixed analysis using multivariable Cox proportional hazard models. A quadratic mixed-effect model was used to estimate change in average heart rate per year of follow-up. Among different polynomial models, we chose the quadratic 1 which minimized the BIC (Bayesian information criterion). Moreover, we used an extension of the Cox model allowing for introduction of repeated measurements of heart rate over time in a time-dependent analysis. 15 With this version of the Cox model, the risk of event at any time t depends on the last available measure of heart rate before time t. P for trend across categories was obtained by entering heart rate tertiles as a continuous variable. In the first model, we only adjusted for age. In the second model, we entered traditional cardiovascular risk factors, including age, smoking status, systolic blood pressure, antihypertensive treatment, diabetes mellitus, body mass index, total cholesterol, and high-density lipoprotein cholesterol. 16 Among participants, 302 (6.3%) had missing values for ≥1 covariables. The multivariable adjusted analysis was restricted to those participants with complete information on cardiovascular risk factors at baseline. Participants were followed until the occurrence of heart failure, death, or the end of the study period. To evaluate the association between heart rate and incident heart failure not mediated through CHD, we also censored participants at the occurrence of nonfatal CHD. 17 Furthermore, we conducted time-dependent analyses to assess the association between heart rate and incident heart failure not mediated by the use of heart rate influencing medication, as the indication for the prescription of β-blockers or calcium channel blockers might be associated with the risk of heart failure, and these medications affect resting heart rate measurements. This was done by changing the exposure of the participants whenever they filled-out a prescription of β-blockers or calcium channel blockers during follow-up. 18 In the sensitivity analyses, we repeated all analyses using time-fixed and time-dependent resting heart rate measured by ECG because ECG-derived heart rate is more accurate. 19 We report estimates with 
Results
Sex-specific baseline characteristics with respect to resting heart rate categories are presented in Table 1 . Mean age of the participants was 68.5 years and 62% were women. In men, heart rate was ≤68 beats per minute for the first tertile, 69 to 78 beats per minute for the second tertile, and ≥79 beats per minute for the third tertile. In women, these rates were ≤72, 73 to 80, and ≥81 beats per minute, respectively. Participants in the highest heart rate tertile were more likely to smoke, and to have elevated blood pressure and diabetes mellitus. No differences in the use of antihypertensive drugs were found across heart rate categories, but a higher heart rate was more frequently noted in male users of antiasthmatics and female users of oral corticosteroids. Average resting heart rate decreased similarly in both sexes during follow-up, but tended to stabilize over time (Figure in the online-only Data Supplement). During a median (interquartile range) of 14.6 (7.6) years of follow-up, 656 participants developed incident heart failure. Crude incidence rates of heart failure were higher in men with higher heart rate than in men with lower heart rate, with 13.7 versus 9.9 per 1000 person-years. In women, crude incidence rates of heart failure were similar across heart rate categories, except when heart rate was measured with ECG ( Figure) . Accordingly, there were remarkable differences in adjusted hazard ratios between men and women. The multiplicative interaction term between heart rate as a continuous variable and sex was significant both in the age-and sex-adjusted model (P=0.011) and in the multivariable adjusted model (P=0.004). For each increment of 10 beats per minute, the multivariable adjusted hazard ratios in men were 1.16 (95% confidence interval, 1.05-1.28) in the time-fixed heart rate model and 1.13 (95% confidence interval, 1.02-1.25) in the time-dependent heart rate model ( Table 2 ). Further adjustment for use of antiasthmatic drugs and corticosteroids use did not change the estimates. In women, resting heart rate was not associated with a higher heart failure risk ( Table 2) .
To assess the heart failure risk not mediated by CHD, we also censored 328 participants at the occurrence of nonfatal CHD during follow-up. This yielded similar results (Table 3) . We also examined the risk of heart failure, taking into account follow-up time until the first prescription of common heart rate-lowering drugs. This represented 1700 first prescriptions, including 248 prescriptions before the diagnosis of heart failure. In this analysis, men with a heart rate in the upper tertile compared with those with a heart rate in the lower tertile had a higher risk of heart failure with a multivariable adjusted hazard ratio of 1.47 (95% confidence interval, 1.08-2.01).
Relative risk estimates were not significant and unchanged in women (Table 3) .
Sensitivity Analysis (Heart Rate Measured With ECG)
Using resting heart rate measured by ECG instead of pulse measurement, baseline heart rate was generally somewhat lower resulting in ≤62 beats per minute for the first tertile, 63 to 73 beats per minute for the second tertile, and ≥74 beats per minute for the third tertile in men, and ≤69, 69 to 76, and ≥77 beats per minute in women, respectively (Table in the online-only Data Supplement). However, for each increment of 10 beats per minute in men, we still found a significant 13% higher heart failure rate for the time-fixed heart rate model and 18% higher rate for the time-dependent heart rate model (Table 4 ). In women, the association did not reach statistical significance in the multivariable models. Further excluding 10 men and 7 women with a resting heart rate <50 beats per minute, for example, with bradycardia, yielded similar results.
Discussion
In a large population-based cohort study of healthy adults, higher resting heart rate measured with pulse palpation (and alternatively by ECG) was independently associated with incident heart failure in men during follow-up, and this association Figure. Cumulative incidence of heart failure according to tertile of baseline heart rate, by sex. A, Heart rate measured at the radial artery for 30 s (n=4768). B, Heart rate measured from a 10-s ECG (n=4127).
was not mediated through overt CHD. The association was found significant in men both with single and repeated heart rate measurement over time. In women, the association could not be demonstrated. Our study highlights the importance of resting heart rate as an independent marker of future heart failure in middle-aged and older healthy men from the general population.
Previous studies have reported that heart rate is a prognostic and potentially modifiable marker in patients experiencing heart failure or CHD. 3 In a convenient sample of patients with CHD, Diaz et al 5 demonstrated that heart rate was associated with incident heart failure hospitalization. However, both the basic hemodynamic response to a decompensated state and the excessive neuroendocrine activation cause tachycardia in patients with subclinical heart failure. 20 Thus, the pathogenic nature of the association between heart rate and incident heart failure can only be examined in subjects without pre-existing overt cardiac disease at baseline. In line with our results, investigators from the EPIC-Norfolk study recently reported on a positive association between a single heart rate measurement and heart failure in middle-aged adults from the general population. 7 In addition to the EPIC-Norfolk study, we could demonstrate that the association was not influenced by variation of resting heart rate over time or by the measurement method used to assess heart rate. Furthermore, participants of the EPIC-Norfolk study may still have had subclinical heart disease because they relied on the use of medication only to define prevalent heart failure cases, as well as self-reported CHD, and they did not exclude adults with pre-existing atrial fibrillation or other conduction disorders based on ECG. Finally, the EPIC-Norfolk study examined only incident heart failure hospitalization, without including diagnoses of heart failure made by general practitioners or nursing home physicians as in our study.
As confirmed in our data, resting heart rate is higher in women than in men.
14 Sex differences have also been proposed in heart failure pathogenesis; in men, CHD is considered the most important determinant, whereas in women hypertension plays a more predominant role. 21 In our study sample, resting heart rate showed a stronger association in men than in women for the development of heart failure, but hypertension was associated with incident heart failure both in men and in women without a significant sex difference (P for interaction 0.77). Resting heart rate in women may be less precise because of more important endogenous variations and previous experiences with cardiac volume overload during pregnancy. Indeed, the healthy female heart might have an advantage to adapt to elevated heart rate and volume overload related to pregnancy, offering protection against heart failure.
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Our results are in line with those from the EPIC-Norfolk study examining adults from the general population, in which the investigators could not find a statistically significant association between heart rate and heart failure in women not taking heart rate-lowering drugs, with a P for trend of 0.055 across heart rate categories. 7 We could further demonstrate that higher heart rate was an independent marker of heart failure that was not preceded by CHD, or by the use of β-blockers or calcium channel blockers during follow-up. Through mechanisms linked to oscillatory shear stress in the coronary arteries, an elevated heart rate might promote coronary atherosclerosis. 3 In our study, it seems unlikely that the higher incidence of heart failure that we observed in adults with a higher heart rate was mediated by CHD. Current guidelines for the prevention of heart failure classify heart rate as a minor clinical risk factor, probably because the pathophysiological pathways between heart rate and heart failure remain speculative. 23 Recently, 2 clinical trials reported the additional benefit of a specific heart rate-lowering drug on outcomes in patients with heart failure and heart rate >75 beats per minute. 24, 25 Interestingly, in SHIFT (Systolic Heart failure treatment with the I f inhibitor ivabradine Trial), women seemed to derive equal benefit than men from the heart rate-lowering drug to avoid rehospitalization for heart failure. 25 Specific heart rate reducing therapy should be considered for evaluation in healthy adults with elevated heart rate to prevent or postpone the development of heart failure.
Strengths of our study include the large sample size in a population-based setting with a long follow-up, the repeated measurement of resting heart rate over time, the concurrent assessment of resting heart rate by means of both arterial pulse and ECG recording, and the large number of heart failure cases adjudicated using standardized definitions. The detection of heart failure relied not only on hospitalization, but also included diagnoses of heart failure made by general practitioners and nursing home physicians. This systematic approach potentially reduced selection of severe cases only. Previous studies have evaluated risk factors for incident heart failure on the basis of ECG measurement. 6, 8 The ECG provides important clinical information other than heart rate, such as presence of left ventricular hypertrophy, bundlebranch blocks, or ST-T abnormalities that might together improve cardiovascular risk prediction. 26 In our study, we showed that a single or repeated assessment of heart rate based on arterial pulse was sufficient to identify men at higher risk of developing heart failure. However, our study also has some limitations. The association between heart rate and heart failure in our population of healthy older adults suggests that heart rate is not merely a surrogate marker of an underlying process leading to heart failure. However, even with a comprehensive assessment of traditional cardiovascular risk factors, we cannot rule out residual confounding. For example, we could not account for the circadian variation of resting heart rate in our analyses. However, the circadian variation of heart rate is small between 10:00 AM and 6:00 PM and tends to diminish in older adults. 27 Similar to previous reports, 6, 8 we were also unable to account for the degree of physical activity performed by each participant, and therefore the associations found with heart rate may be confounded by physical fitness. Finally, we could not assess cardiac changes or differentiate between echocardiographic systolic and diastolic dysfunction in our study. Therefore, further studies should better characterize healthy men and women with elevated heart rate, for instance using echocardiography or B-type natriuretic peptide measurements.
In conclusion, in our population-based study of adults free of heart disease, both single and repeated measurements of resting heart rate based on pulse palpation or alternatively ECG identifies men at higher risk of developing heart failure, beyond other cardiovascular risk factors. Whether healthy older individuals with higher resting heart rate might benefit from preventive therapy that specifically reduces heart rate remains to be explored.
